The least-known character in the history of the Pill is Ludwig Haberlandt, professor of physiology at the University of Innsbruck. As early as 1919, he started on a pioneering series of crucial experiments (described in detail in this issue of Wiener klinische Wochenschrift by his granddaughter, Dr. Edda Haberlandt) on what he called "hormonal temporary sterilization" -work that was supported financially for years by the Rockefeller Foundation. In publications over the course of ten years, Haberlandt -invariably using the first person singular (because he essentially worked alone), so strikingly different from the royal "we" of today's scientists -emphasized the obvious applicability of his animal experiments to human contraception. He fully recognized that the responsible factor was a constituent of the corpus luteum, although at that time the pure active principle, progesterone, had neither been isolated nor yet synthesized.
In 1931, in a remarkable book, Die hor monale Sterilisie rung des weiblichen Organismus, of less than 15,000 words that hardly any reproductive biologist now living seems to have read, Haberlandt outlined in uncanny detail the contraceptive revolution of some thirty years later. He pointed out that oral administration would be the method of choice as well as the necessity for periodic withdrawal from the hormone to allow menses to occur. He called for the use of such contraception on clinical and eugenic grounds, arguing that it would enable parents to have the desired number of healthy children.
Objections by people like the sexologist van de Velde that too many women would take advantage of hormonal contraception was dismissed by Haberlandt with the argument that such preparations would require a physician's prescription and would not be made available over the counter. Within two years of his death, pure progesterone was isolated in no less than four laboratories in Germany, the US, and Switzerland; its chemical structure established by Karl Slotta (eventually, a Hitler refugee settling in Brazil); and its synthesis from the soyasterol stigmasterol accomplished. Had Haberlandt lived, there is no question that he would have pursued his dream of temporary hormonal sterilization in humans without resorting to glandular extracts. But even with pure progesterone, he could have shown only that ovulation can be inhibited by injection. For oral administration, he would have needed another steroid -not naturally occurring, but waiting to be synthesized -and that took twenty more years. Thus, nothing further happened, and Haberlandt's work fell into such oblivion that theerlandt's pioneering earlier research. Yet if there ever was a grandfather of the Pill, Ludwig Haberlandt above all others deserves that honor.
Much of what I say above comes from a memoir 1 of mine written on the 50 th birthday of the first chemical synthesis of an orally active progestin, norethindrone, which we accomplished 2 in the research laboratories of a minute Mexican pharmaceutical company, Syntex S.A. Within weeks of that synthesis on October 15, 1951, we had sent samples of this powerful, orally active progestin to various biologists: Roy Hertz (Bethesda, MD); Alexander Lipschütz (Santiago, Chile); Gregory Pincus
